Drugs / AGN-232411
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02420730 | Jun 2015 → Mar 2016 | dry eye syndrome | Allergan | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGN-232411 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02420730 ↗ |
| Route | Topical | “AGN-232411 topical ophthalmic solution” NCT02420730 ↗ |